Pittsburgh Undergraduate Research Diversity Program (PURDIP)

匹兹堡本科生研究多样性计划(PURDIP)

基本信息

项目摘要

ABSTRACT The goal of the Pittsburgh Undergraduate Research Diversity Program (PURDIP) is to catalyze the training and career development of underrepresented minority undergraduate students in research, to enhance the diversity of the biomedical, behavioral, and clinical research workforce in the mission areas of importance to the NHLBI. This goal will be achieved through the provision of an intensive summer research educational experience in innovative technologies and conceptual paradigms related to heart, lung, blood and sleep-related science at the University of Pittsburgh. The focus of PURDIP is knowledge in Fundamentals of Biomedical and Behavioral Research and Health Disparity, Mentored Research Projects and Learning Skills. Its objective is to help the students discover their passion for research in heart, lung, sleep and blood science, provide hands-on research experience to trainees to help them to better understand the biomedical, behavioral and clinical research profession, and finally to motivate the trainees to continue on to graduate and other health professions careers. Over 70 University of Pittsburgh academic faculty from the broad disciplines of cardiology, hematology/oncology, vascular biology, molecular biology, pharmacology, coagulation and thrombosis, transfusion medicine, regenerative medicine and sleep at the University of Pittsburgh are available to provide a broad array of basic, behavioral, translational and clinical research topics and study patient populations to carry out this project. The program is focused on multiple areas of heart, lung, blood and sleep research including hemolysis-related vascular disorders, sickle cell disease, pulmonary hypertension, cardiac imaging, and cardiovascular health outcomes. Training will incorporate the learning of cutting edge methodologies that is applied to a clinical problem, leading to potentially novel therapeutic approaches or clinical studies in patients. Trainees will be paired up with one clinical investigator and one basic or behavioral investigator to give them a broad perspective on health-related research.
摘要 匹兹堡本科生研究多样性计划(PURDIP)的目标是促进培训和 少数民族大学生职业生涯发展研究,增强多样性 对NHLBI具有重要意义的任务区的生物医学、行为和临床研究人员。 这一目标将通过提供密集的暑期研究教育体验来实现。 与心、肺、血液和睡眠相关科学有关的创新技术和概念范例 匹兹堡大学。PURDIP的重点是生物医学和行为学基础知识 研究和健康差距,有指导的研究项目和学习技能。它的目标是帮助 学生发现他们对心、肺、睡眠和血液科学的研究热情,提供动手研究 为学员提供经验,帮助他们更好地了解生物医学、行为和临床研究 最后,激励受训者继续从事毕业和其他卫生专业的职业。 匹兹堡大学70多名学术教师来自心脏病学、血液学/肿瘤学等广泛学科, 血管生物学、分子生物学、药理学、凝血与血栓形成、输血医学、 匹兹堡大学的再生医学和睡眠可提供广泛的基础、 行为、翻译和临床研究主题和研究患者群体,以开展这一项目。这个 该计划专注于心、肺、血液和睡眠的多个领域的研究,包括与溶血相关的研究 血管疾病、镰状细胞病、肺动脉高压、心脏成像和心血管健康 结果。培训将包括学习应用于临床的尖端方法 问题,导致潜在的新的治疗方法或患者的临床研究。实习生将被配对 最多配备一名临床调查员和一名基础或行为调查员,为他们提供广泛的视角 健康相关研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Solomon Fiifi Ofori-Acquah其他文献

White Matter Injury in Sickle Cell Mice Is Associated with Reduced Neurocognitive Function and Activation of Astrocytes
  • DOI:
    10.1182/blood-2022-169094
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Rimi Hazra;Hongjan Pu;Lesley M. Foley;T. Kevin Hitchens;Lynda Little-Ihrig;Samit Ghosh;Solomon Fiifi Ofori-Acquah;Xiaoming Hu;Enrico M. Novelli
  • 通讯作者:
    Enrico M. Novelli
Impact of Iron Supplementation in Anemic Voluntary First-Time Blood Donors-Results of a Pilot Trial in Ghana
  • DOI:
    10.1182/blood-2023-174351
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Yvonne Dei Adomakoh;Edeghonghon Olayemi;Lucy Asamoah-Akuoko;Bernard Appiah;Susan Telke;Catherine I. Segbefia;Tara Tancred;Seth Adu-Afarwuah;Amma A. Benneh-Akwasi Kuma;Alfred Edwin Yawson;Solomon Fiifi Ofori-Acquah;Philip Baba Adongo;Reena Ametorwo;Imelda Bates;Cavan Reilly;The BLOODSAFE Investigators
  • 通讯作者:
    The BLOODSAFE Investigators
Enhanced Expression of Heme Oxygenase-1 (HO-1) Among Children with Sickle Cell Disease: Results of the Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Study
  • DOI:
    10.1182/blood-2023-189608
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Anna Sowa;William Kudzi;Vivian Paintsil;Amma A. Benneh-Akwasi Kuma;Catherine I. Segbefia;Edeghonghon Olayemi;David Adjei;Anastasia Bruce;Jeff Gruen;Ellis Owusu-Dabo;Solomon Fiifi Ofori-Acquah;The SickleGenAfrica Network
  • 通讯作者:
    The SickleGenAfrica Network
Effectiveness of Hydroxyurea in Patients with Sickle Cell Disease in Ghana: A Population-Level, Healthcare Facilities-Based Study
  • DOI:
    10.1182/blood-2024-209483
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Duah Dwomoh;Daniel Nana Yaw Abankwah;Amma Benneh-Akwasi Kuma;Jonathan Spector;Jonathan Quartey;Olufolake A. Egbujo;Kwaku Marfo;Solomon Fiifi Ofori-Acquah;Justice Nonvignon
  • 通讯作者:
    Justice Nonvignon
Utilization of Digital Applications to Support Provision of Comprehensive Sickle Cell Disease Management
  • DOI:
    10.1182/blood-2024-209803
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Duah Dwomoh;Daniel Nana Yaw Abankwah;Amma Benneh-Akwasi Kuma;Jonathan Spector;Jonathan Quartey;Olufolake A. Egbujo;Kwaku Marfo;Solomon Fiifi Ofori-Acquah;Justice Nonvignon
  • 通讯作者:
    Justice Nonvignon

Solomon Fiifi Ofori-Acquah的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Solomon Fiifi Ofori-Acquah', 18)}}的其他基金

Therapeutic Targets in Acute Chest Syndrome
急性胸部综合症的治疗目标
  • 批准号:
    10391713
  • 财政年份:
    2022
  • 资助金额:
    $ 12.2万
  • 项目类别:
Therapeutic Targets in Acute Chest Syndrome
急性胸部综合症的治疗目标
  • 批准号:
    10565873
  • 财政年份:
    2022
  • 资助金额:
    $ 12.2万
  • 项目类别:
Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium
加纳-SPARCO:加纳镰刀泛非研究联盟
  • 批准号:
    10625460
  • 财政年份:
    2021
  • 资助金额:
    $ 12.2万
  • 项目类别:
Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium
加纳-SPARCO:加纳镰刀泛非研究联盟
  • 批准号:
    10402928
  • 财政年份:
    2021
  • 资助金额:
    $ 12.2万
  • 项目类别:
Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium
加纳-SPARCO:加纳镰刀泛非研究联盟
  • 批准号:
    10186856
  • 财政年份:
    2021
  • 资助金额:
    $ 12.2万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10000990
  • 财政年份:
    2017
  • 资助金额:
    $ 12.2万
  • 项目类别:
Genetic determinants of hemolysis modifying defense in sickle cell disease
镰状细胞病溶血改变防御的遗传决定因素
  • 批准号:
    10240498
  • 财政年份:
    2017
  • 资助金额:
    $ 12.2万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10240493
  • 财政年份:
    2017
  • 资助金额:
    $ 12.2万
  • 项目类别:
Genetic determinants of hemolysis modifying defense in sickle cell disease
镰状细胞病溶血改变防御的遗传决定因素
  • 批准号:
    10000996
  • 财政年份:
    2017
  • 资助金额:
    $ 12.2万
  • 项目类别:
Pittsburgh Undergraduate Research Diversity Program (PURDIP)
匹兹堡本科生研究多样性计划(PURDIP)
  • 批准号:
    9017260
  • 财政年份:
    2016
  • 资助金额:
    $ 12.2万
  • 项目类别:

相似海外基金

Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7462657
  • 财政年份:
    2008
  • 资助金额:
    $ 12.2万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    8013895
  • 财政年份:
    2008
  • 资助金额:
    $ 12.2万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7755368
  • 财政年份:
    2008
  • 资助金额:
    $ 12.2万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7586197
  • 财政年份:
    2008
  • 资助金额:
    $ 12.2万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10132461
  • 财政年份:
    1997
  • 资助金额:
    $ 12.2万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10331060
  • 财政年份:
    1997
  • 资助金额:
    $ 12.2万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10597891
  • 财政年份:
    1997
  • 资助金额:
    $ 12.2万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10178913
  • 财政年份:
    1997
  • 资助金额:
    $ 12.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了